Advocacy Relations News
Industry and Government Deepen Relationship to Drive Drug Delivery Solutions
Who says you can't teach old dogs new tricks?
more
One Size Does NOT Fit All
When it comes to patient communications across cultures, don't let your message get lost in translation.
more
2012 GI Cancers Symposium – Advancements in the Colorectal Cancer Landscape
For the ninth year oncologists, researchers, patient advocates and health professionals recently gathered in San Francisco at the Gastrointestinal (GI) Cancers Symposium. The three-day multidisciplinary meeting focused on discussing major developments and strategies in preventing, screening and treating GI cancers.
more
EMCC – Promoting Dialogue on Access
JPA had the great opportunity to attend the European Multidisciplinary Cancer Congress (EMCC) in Stockholm, Sweden, which is concluding today.
more
The Drug Development Game
With a focus on risk rather than reward— some suggest that the FDA and Congress are deterring pharmaceutical innovation.
more
Advocacy Across Borders
Navigating the regulations that inform ethical interaction with patient advocates can be a challenge, especially for those working in both the US and Europe.
more
European Haematology Association’s 16th Congress
At this year’s meeting, in addition to the usual clinical data presentations, patient advocates were given a platform to share their perspective on the treatment and management of haematologic cancers.
more
2011 Annual Meeting of the American Society of Clinical Oncology (ASCO)
Once again, the city of Chicago hosted the leading minds in cancer care, as thousands of researchers, health professional and advocates convened for the 2011 Annual Meeting of the American Society of Clinical Oncology (ASCO).
more
Understanding Patient Drug Access Programs
Patient assistance programs. Expanded access programs. What is the difference?
more
